Received Aug 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (TRUMENBA) | PFIZER\WYETH | 1 | — | — |
feeling sick after the first dose; This is a spontaneous report received from a Pharmacist from medical information team. A patient (age and gender not provided) received meningococcal group b Rlp2086 (TRUMENBA), in Mar2024 as dose 1, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 2024, outcome "unknown", described as "feeling sick after the first dose". Additional information: The pharmacist reported that I have a patient that requires the Trumenba two dose series. Patient initially received first dose March of 2024 but reported feeling sick after the first dose so did not follow-up for 2nd dose 6 months later. Patient is now interested in completing the series. Does the patient need to restart the series or can they just receive one more dose?. The information on the batch/lot number for meningococcal group b Rlp2086 will be requested and submitted if and when received.